Clinical trial Recruiting at 1 site Observational Ages 18 and up

Survey on medication information leaflets for organ transplant patients

Official title: Development and Validation of Materials for the Pharmaceutical Care of Organ Transplant Recipients in Community Pharmacy: Survey on the Evaluation of Medication Information Leaflets for Organ Transplant Patients

Run by Universität Münster · NCT06652919 · Data updated 2026-11-12

This study is trying to find out what organ transplant patients and their caregivers think about the medication information leaflets to make them clearer and more helpful.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorUniversität Münster
Academic / other
Locations1 site (Münster, North Rhine-Westphalia)
StatusRecruiting
StartedNovember 6, 2024
Main results expectedJanuary 2025
Study endsMarch 2025
Registry record updatedNovember 8, 2024
Trial IDNCT06652919 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adult organ transplant patients or their caregivers who are German-speaking and currently taking immunosuppressants.

Probably not a fit

Patients who are not able to provide consent, non-German speakers, those under 18 years old, or individuals who have undergone transplantation but are no longer taking immunosuppressants may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to gather feedback from organ transplant patients and their caregivers regarding the medication information leaflets developed for them. Using a questionnaire, the study will assess the effectiveness and clarity of these leaflets to ensure they meet the specific needs of this patient population. The feedback will be used to refine the content of the leaflets, enhancing patient understanding and adherence to their medication regimens. The study highlights the importance of tailored pharmaceutical care for organ transplant recipients.

Why it matters

Potential benefit: If successful, this study could improve patient understanding and adherence to medication regimens, leading to better health outcomes for organ transplant recipients.

How similar studies have gone: While this approach is focused on patient feedback for medication leaflets, similar studies have shown that tailored information can significantly enhance patient adherence and safety in medication management.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients who have undergone solid organ transplantation (kidney, liver, heart, lung)
* Caregivers or family members of organ transplant patients
* German-speaking individuals
* adult

Exclusion Criteria:

* Individuals who are not able to provide consent
* Non-German-speaking individuals
* under 18 years old
* Patients who have undergone organ transplantation and are no longer taking immunosuppressants

Where it's running

  • Institute of Pharmaceutical and Medicinal Chemistry, Clinical Pharmacy, University of Münster
    Münster, North Rhine-Westphalia, Germany
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.